PeraHealth

What PeraHealth does

PeraHealth is a Charlotte, North Carolina-based healthcare technology company founded in 2008 that develops the Rothman Index, an FDA-cleared artificial intelligence predictive analytics system designed to detect early signs of patient deterioration in hospital settings. The platform automatically extracts and analyzes continuously changing clinical measurements from the Electronic Medical Record (EMR), including vital signs, laboratory results, and complete head-to-toe nursing assessments, and uses proprietary algorithms to compute an aggregated score of a patient's overall physiological condition. The company's stated differentiator is detection of subtle deterioration trends up to 24 hours before conventional bedside alarms trigger, with documented clinical outcomes including a 16% mortality reduction at one California hospital and reported identification of 70-80% of code blue patients prior to the event.

PeraHealth's product portfolio comprises three offerings: the core Rothman Index (the underlying patient-condition score), Rothman Index Trend (a population-level surveillance dashboard supporting shift handoffs and multi-disciplinary rounds), and Rothman Index for Pediatrics (specialized algorithms for pediatric patients). The technology is delivered via integration with hospital EMR/EHR systems and can be accessed through a web browser, EHR integration, or a dedicated command center, and is applicable across medical/surgical units, intermediate care, and intensive care locations. The company has accumulated more than 55 peer-reviewed publications supporting the clinical effectiveness of the technology, and the Rothman Index is a registered trademark.

The company operates on an OEM/whitelabel technology licensing model rather than direct enterprise sales. Its primary distribution partner is Spacelabs Healthcare (a wholly owned subsidiary of OSI Systems, Inc., NASDAQ: OSIS), which licenses the Rothman Index from PeraHealth and embeds it within its SaaS predictive analytics portfolio sold to hospitals and health systems globally. Pricing is not publicly disclosed and is set by partner companies rather than PeraHealth directly. The company is privately held, employs between 11 and 50 people, and its most recent disclosed funding event was a $14 million growth round led by Mainsail Partners in January 2017.

Name

PeraHealth

Legal name

Spacelabs Healthcare

Website

https://perahealth.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Clinical Decision Support / Healthcare Predictive Analytics

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Fall Detection, Safety & Emergency Response (PERS, Smart Home Health Sensors) (HLAHACAG)

Keywords

• Clinical predictive analytics
• Early warning systems
• Patient deterioration detection
• EMR clinical decision support
• Healthcare AI software

Headquarters

HQ city

Charlotte

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Technology Licensing - OEM/Whitelabel: PeraHealth licenses its Rothman Index technology to partners like Spacelabs Healthcare who incorporate it into their product offerings. Revenue is generated through licensing agreements with healthcare equipment and software companies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

PeraHealth develops and licenses the Rothman Index, an FDA-cleared AI predictive analytics system that automatically extracts and analyzes clinical data from the EMR — including vital signs, lab results, and head-to-toe nursing assessments — to detect subtle patient deterioration up to 24 hours before alarms sound. The platform is offered as a SaaS portfolio through OEM/whitelabel partners such as Spacelabs Healthcare, covering adult, pediatric, and population-level surveillance use cases for hospitals and health systems.

Product overview

PeraHealth offers the Rothman Index as a unified FDA-cleared AI predictive analytics platform designed for early detection and intervention of patient deterioration. The core Rothman Index product automatically extracts and analyzes clinical measurements from EMR systems, including nursing assessments, to generate an aggregated patient condition score. The platform is offered as SaaS and includes sub-products: Rothman Index Trend (population-level surveillance dashboard supporting care transitions) and Rothman Index for Pediatrics (specialized algorithms for pediatric patients). The system is applicable across medical/surgical units, intermediate care, and intensive care locations.

Differentiator

Problem solved

Functional benefit

Products and services

• Rothman Index

Quantifiable outcome

• 16% decrease in mortality rate at California hospital
• +4 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability2 records

Feature3 records

Partnerships

One partnership is on record.

• Spacelabs HealthcarecoreOEM/ Whitelabel/ Licensing PartnerSpacelabs Healthcare is a key OEM/whitelabel partner that licenses the Rothman Index technology from PeraHealth. Spacelabs incorporates the FDA-cleared AI predictive analytics system into their SaaS portfolio, marketing and distributing it to hospitals and health systems as part of their patient monitoring and analytics offerings.

Scale indicators2 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Spacelabs Healthcare: Spacelabs Healthcare is PeraHealth's primary OEM distribution partner and embeds the Rothman Index directly in its predictive analytics SaaS portfolio sold to hospitals. Both companies sell into the same hospital early-warning/predictive analytics buyer, making Spacelabs the closest commercial analog even though it is also a partner.

Broad incumbents

• Epic Systems (Deterioration Index): Epic bundles a Deterioration Index natively into its EHR, which competes directly with the Rothman Index for the same nurse-and-physician early-warning workflow. As the dominant hospital EHR vendor, Epic is the single most consequential incumbent competitor for PeraHealth's category.
• GE HealthCare (Mural): GE HealthCare's Mural platform offers hospital-wide patient deterioration and sepsis prediction as part of its broader command-center and patient monitoring suite. It overlaps with PeraHealth's clinical use cases through a much larger installed footprint.
• Philips (IntelliVue & early warning analytics): Philips provides patient monitoring hardware and analytics (IntelliVue and connected care solutions), including early-warning scores for hospitalized patients. It competes with PeraHealth across the same continuous-monitoring and deterioration-detection use cases at a broader portfolio scale.
• Medidata / Medidata AI (early warning modules): Medidata and adjacent Medtronic clinical solutions offer algorithm-driven patient monitoring analytics integrated into hospital surveillance workflows, overlapping with Rothman Index in continuous patient condition scoring.

Emerging players

• Dascena (now Inseparable AI): Dascena/Inseparable AI developed AI algorithms for early detection of patient deterioration, sepsis, and acute kidney injury using EHR data - a head-to-head technical and clinical peer to the Rothman Index in the in-hospital predictive analytics category.
• CLEW Medical: CLEW Medical builds AI-driven predictive analytics for ICU patient deterioration and clinical resource optimization. It targets the same acute-care customer base and similar early-warning use cases that PeraHealth addresses with the Rothman Index.
• Excel Medical Electronics: Excel Medical provides FDA-cleared early-warning software and patient surveillance platforms used in hospital ICUs and step-down units. It competes directly with PeraHealth in the AI-driven patient deterioration detection category.
• Hospital IQ: Hospital IQ applies predictive analytics to hospital operations and clinical decision support. While more operational, it competes for the same analytics-driven decision-making buyer that PeraHealth targets with its deterioration scores.
• EarlySense: EarlySense provides continuous patient monitoring sensors and contact-free deterioration detection technology for hospital and post-acute settings. It offers a different input modality (sensor-based) but targets overlapping deterioration-detection use cases in the same clinical buyer group.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/PeraHealth
• LinkedInlinkedin.com/company/perahealth-inc-

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PeraHealth